Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

CLL and breast cancer differ in the expression of regulatory microRNAs

Publish date:: March 25, 2020

Key clinical point: Chronic lymphocytic leukemia and breast cancer microRNAs show diagnostic and prognostic potential.

Major finding: Studied microRNA expression in breast cancer and chronic lymphocytic leukemia patients was significantly higher than in healthy controls (P less than .001).

Study details: A molecular analysis of blood from 15 chronic lymphocytic leukemia patients and tissue samples from 15 breast cancer patients.

Disclosures: The authors reported that they had no competing interests.

Citation:

Raeisi F et al. Mol Ther Oncolytics. 2020;16:230-7.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Breast Cancer

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Study: Doctors underreport side effects of breast irradiation,

No edge for anastrozole over tamoxifen in DCIS,

Long-term APBI cosmetic, toxicity data reported WBI has the edge Practice-confirming results,

Omitting postop radiotherapy doesn’t affect survival in older breast cancer patients,